Analysen zu Roche AG (Genussschein)
| 10.02.26 | Roche Overweight | Barclays Capital | |
| 09.02.26 | Roche Overweight | Barclays Capital | |
| 02.02.26 | Roche Kaufen | DZ BANK | |
| 30.01.26 | Roche Buy | UBS AG | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 29.01.26 | Roche Outperform | Bernstein Research | |
| 27.01.26 | Roche Overweight | Barclays Capital | |
| 16.01.26 | Roche Buy | UBS AG | |
| 15.01.26 | Roche Overweight | Barclays Capital | |
| 09.01.26 | Roche Outperform | Bernstein Research | |
| 07.01.26 | Roche Overweight | Barclays Capital | |
| 11.12.25 | Roche Buy | UBS AG | |
| 05.12.25 | Roche Buy | UBS AG | |
| 19.11.25 | Roche Buy | UBS AG | |
| 10.11.25 | Roche Buy | UBS AG | |
| 27.10.25 | Roche Outperform | Bernstein Research | |
| 23.10.25 | Roche Kaufen | DZ BANK | |
| 23.10.25 | Roche Buy | UBS AG | |
| 16.10.25 | Roche Kaufen | DZ BANK | |
| 13.10.25 | Roche Buy | UBS AG | |
| 23.09.25 | Roche Buy | UBS AG | |
| 04.09.25 | Roche Buy | UBS AG | |
| 01.08.25 | Roche Outperform | Bernstein Research | |
| 28.07.25 | Roche Buy | UBS AG | |
| 25.07.25 | Roche Kaufen | DZ BANK | |
| 24.07.25 | Roche Buy | UBS AG | |
| 24.07.25 | Roche Outperform | Bernstein Research | |
| 10.07.25 | Roche Buy | UBS AG | |
| 01.07.25 | Roche Buy | UBS AG | |
| 16.06.25 | Roche Buy | UBS AG | |
| 28.05.25 | Roche Buy | UBS AG | |
| 09.05.25 | Roche Buy | UBS AG | |
| 25.04.25 | Roche Buy | UBS AG | |
| 24.04.25 | Roche Kaufen | DZ BANK | |
| 24.04.25 | Roche Buy | UBS AG | |
| 24.04.25 | Roche Outperform | Bernstein Research | |
| 14.04.25 | Roche Buy | UBS AG | |
| 07.04.25 | Roche Buy | UBS AG | |
| 03.04.25 | Roche Outperform | Bernstein Research | |
| 12.03.25 | Roche Outperform | Bernstein Research | |
| 12.03.25 | Roche Buy | UBS AG | |
| 21.02.25 | Roche Buy | UBS AG | |
| 20.02.25 | Roche Outperform | Bernstein Research | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 07.01.25 | Roche Outperform | Bernstein Research | |
| 24.10.24 | Roche Kaufen | DZ BANK | |
| 29.08.24 | Roche Outperform | Bernstein Research | |
| 25.07.24 | Roche Kaufen | DZ BANK | |
| 24.04.24 | Roche Kaufen | DZ BANK |
Aktuelle Aktienanalysen
| 25.02.26 | Allianz Hold | Jefferies & Company Inc. | |
| 25.02.26 | Knorr-Bremse Buy | Goldman Sachs Group Inc. | |
| 25.02.26 | Volkswagen Neutral | Goldman Sachs Group Inc. | |
| 25.02.26 | Porsche vz. Neutral | Goldman Sachs Group Inc. | |
| 25.02.26 | Enel Buy | Goldman Sachs Group Inc. | |
| 25.02.26 | Fresenius Overweight | Barclays Capital | |
| 25.02.26 | Danone Overweight | JP Morgan Chase & Co. | |
| 25.02.26 | Heidelberg Materials Sector Perform | RBC Capital Markets | |
| 25.02.26 | Fielmann Kaufen | DZ BANK | |
| 25.02.26 | E.ON Market-Perform | Bernstein Research | |
| 25.02.26 | E.ON Overweight | JP Morgan Chase & Co. | |
| 25.02.26 | Münchener Rückversicherungs-Gesellschaft Hold | Jefferies & Company Inc. | |
| 25.02.26 | Salzgitter Halten | DZ BANK | |
| 25.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.02.26 | Diageo Overweight | Barclays Capital | |
| 25.02.26 | GSK Underweight | Barclays Capital | |
| 25.02.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 25.02.26 | Santander Outperform | RBC Capital Markets | |
| 25.02.26 | Diageo Outperform | RBC Capital Markets | |
| 25.02.26 | Heidelberg Materials Sector Perform | RBC Capital Markets | |
| 25.02.26 | AIR France-KLM Neutral | UBS AG | |
| 25.02.26 | Air Liquide Buy | UBS AG | |
| 25.02.26 | Iberdrola Neutral | JP Morgan Chase & Co. | |
| 25.02.26 | Linde Outperform | Bernstein Research | |
| 25.02.26 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 25.02.26 | Fresenius Kaufen | DZ BANK | |
| 25.02.26 | Wienerberger buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.02.26 | HELLA Hold | Deutsche Bank AG | |
| 25.02.26 | SFC Energy Hold | Deutsche Bank AG | |
| 25.02.26 | Wienerberger kaufen | Barclays Capital | |
| 25.02.26 | Fresenius Medical Care Hold | Deutsche Bank AG | |
| 25.02.26 | MTU Aero Engines Buy | Deutsche Bank AG | |
| 25.02.26 | AUTO1 Buy | UBS AG | |
| 25.02.26 | SFC Energy Buy | Warburg Research | |
| 25.02.26 | Diageo Overweight | Barclays Capital | |
| 25.02.26 | Santander Overweight | Barclays Capital | |
| 25.02.26 | Schoeller-Bleckmann | Erste Group Bank | |
| 25.02.26 | Wolters Kluwer Overweight | Barclays Capital | |
| 25.02.26 | Santander Buy | Jefferies & Company Inc. | |
| 25.02.26 | Iberdrola Equal Weight | Barclays Capital | |
| 25.02.26 | BAWAG neutral | Erste Group Bank | |
| 25.02.26 | Diageo Neutral | UBS AG | |
| 25.02.26 | E.ON Neutral | UBS AG | |
| 25.02.26 | HSBC Holdings Neutral | UBS AG | |
| 25.02.26 | Heidelberg Materials Buy | UBS AG | |
| 25.02.26 | Fresenius Buy | UBS AG | |
| 25.02.26 | London Stock Exchange Buy | UBS AG | |
| 25.02.26 | E.ON Equal Weight | Barclays Capital | |
| 25.02.26 | Iberdrola Hold | Jefferies & Company Inc. | |
| 25.02.26 | ASML NV Buy | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.